Skye Bioscience (SKYE) Cash & Equivalents (2012 - 2026)
Skye Bioscience's Cash & Equivalents came in at $8.07 million for Q2 2026, down 66.2% from $23.84 million a year earlier and down 1.0% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2025, Skye Bioscience's Cash & Equivalents was $5.88 million, down 91.4% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 19.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $68.42 million in FY2024, $1.26 million in FY2023 (+1.0%), $1.24 million in FY2022 (-86.1%) and $8.98 million in FY2021 (+263.8%).
- The five-year range for quarterly Cash & Equivalents is $415,389 (Q3 2022) to $83.34 million (Q1 2024).
- Year-over-year, Cash & Equivalents has declined for six consecutive quarters, with an average decline of 70.8% over the last six quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2021 (growth of 263.8%), and the weakest in Q3 2022 (a decline of 96.3%).
- Business Quant data shows SKYE's Cash & Equivalents at $8.15 million (Q1 2026), $5.88 million (Q4 2025) and $18.44 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Skye Bioscience | 7.03 Mn | 7.03 Mn | - | 8.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.07 Mn |
| Mar 31, 2026 | 8.15 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 18.44 Mn |
| Jun 30, 2025 | 23.84 Mn |
| Mar 31, 2025 | 46.42 Mn |
| Dec 31, 2024 | 68.42 Mn |
| Sep 30, 2024 | 67.41 Mn |
| Jun 30, 2024 | 74.12 Mn |
| Mar 31, 2024 | 83.34 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 5.13 Mn |
| Jun 30, 2023 | 553,443.00 |
| Mar 31, 2023 | 2.67 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 415,389.00 |
| Jun 30, 2022 | 2.93 Mn |
| Mar 31, 2022 | 6.01 Mn |
| Dec 31, 2021 | 8.98 Mn |
| Sep 30, 2021 | 11.09 Mn |
API Access
Skye Bioscience Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();